This series of phase 3, randomised, double-blind, placebo-controlled clinical trials involved more than 25,000 individuals with overweight or obesity and has extensively demonstrated the efficacy of once-weekly subcutaneous semaglutide 2.4 mg in promoting weight loss [13, 38,39,40,41,42,43,44,45,46]
Yes, Wegovy can cause skin sensitivity in some people
A personalized plan from a qualified physician is the only way to ensure you are maximizing the benefits while protecting your well-being
Heres what we know so far: Cycle Regularity Losing weight can bring numerous health benefits, but it may also cause irregular periods
58 (82.9%) female and 12 (17.1%) male) were randomized: 35 to semaglutide 2.4 mg once weekly plus lifestyle intervention and 35 to placebo plus lifestyle intervention
For most patients, this side effect is mild to moderate in severity and tends to resolve within several weeks as the body adjusts to the medication